Articles scientifiques

Pour télécharger, veuillez cliquer sur les titres.

Gerber et al. (2019). Biophotonic pre-treatment enhances the targeting of senile lentigines with a 694nm QS-Ruby laser

A case study that seeks to investigate the use of Kleresca^® FLE treatments to intensify and demask underlying solar lentigines before their targeting with laser therapy.
The paper shows that Kleresca^® FLE activates the skin cells to successfully intensify all the SL areas to be targeted by the laser treatment and it is a useful adjunct therapy to prepare the skin before and to rejuvenate it after more invasive therapies. Kleresca^® favors a fast recovery and enhances the overall aesthetic results.
Read more about the study in the publication summary.
Koceva, I. et al. Fluorescent light energy: A new therapeutic approach to effectively treating acne conglobata and hidradenitis suppurativa.

The Kleresca^® platform, utilising fluorescent light energy (FLE), effectively treated both acne conglobata and hidradenitis suppurativa. FLE offers a new treatment approach to recalcitrant inflammatory skin conditions.
Edge, D. et al. Fluorescent light energy: the future for treating inflammatory skin conditions?

The study has the aim to investigate the cellular mechanisms of action of FLE on key skin and immune cells . FLE serves both aesthetic and therapeutic purposes by enhancing collagen production, modulatin cutaneuous inflammation and encouraging angiogenesis.
Liu, R. C. et al. 2019. Treatment of granulomatous rosacea with chromophore gel-assisted phototherapy

Patient with a 3 month history of papulopustular eruption result of granulomatous rosacea. A modest improvement was observed with topical systemic treatments. After Kleresca^®, there was a significant improvement and no relapse after 6 months it was finalized.
Mahendran, A. et al. 2018 Treatment of erlotinib-induced acneiform eruption with chromophore gel-assisted phototherapy

Case study of a 49-year old patient suffering from acne eruption induced by erlotinib treatment. After trying different oral and systemic treatments, the use of Kleresca^® Acne Treatment reduce notably the severity of her acne.
Carrasco & Jimenez, 2018. Biophotonic therapy in acne treatments (book chapter in ‘Acne: new therapies and cosmetic treatments’)

A book chapter that explains the clinical experience in the use of Kleresca^® (biophotonic therapy) for the treatment of acne patients. The document explains also the efficacy and the patient satisfaction obtained in the clinic.
Sannino et al., 2018. Fluorescent Light Energy: Treating rosacea subtypes 1, 2 and 3

Three patients were treated with FLE in order to investigate the role in the treatment in targeting inflammation and erythema in rosacea subtypes 1, 2 and 3.
Results proved FLE to be effective with an improvement in the skin texture of the patient.
Jalili, A. 2018. Chromophore gel-assisted phototherapy - A novel and promising photobiomodulation therapy for facial inflammatory skin diseases and skin aging.

Explanatory article about the documented benefits of photobiomodulation and fluorescent light energy (FLE), explaining its benefits in acne, skin rejuvenation, and its potential as an alternative therapeutic option to conventional therapies.
Antoniou, C. et al. 2016. A multicenter, randomized, split-face clinical trial evaluating the efficacy and safety of chromophore gel-assisted blue light phototherapy for the treatment of acne

A 12-week clinical trial to evaluate the efficacy and safety of the biophotonic system in the treatment of moderate to severe acne vulgaris. The treatment was found to be efficacious and safe, with a sustained clinical response at 12 weeks for the management of moderate to severe facial inflammatory acne.
Nikolis, A. 2018. An extension of a multicenter, randomized, split-face clinical trial evaluating the efficacy and safety of chromophore gel-assisted blue light phototherapy for the treatment of acne

Extension trial to evaluate the efficacy of the biophotonic system as well as the duration of response. The study confirmed the long duration of effect following treatment as well as excellent patient safety profile.
Braun, S & Gerber, P. 2017. A photoconverter-gel assisted blue light therapy for the treatment of rosacea

A patient suffering from papulopustular rosacea receives fluorescent light energy (FLE) treatment. After 5 weeks, the patient showed a marked reduction of the inflammatory reaction and an overall improvement of the large-pored skin type.
Scarcella, G. et al. 2018. Treatment of solar lentigines using a combination of picosecond laser and biophotonic treatment

The goal of the study is to combine combines two techniques, (laser and biophotonics) to achieve long-term results with moderate to significant improvement in the overall appearance of facial pigmentation, with high patient satisfaction.
Nielsen, M. et al. 2017. Introducing: Photobiomodulation by low energy chromophore-induced fluorescent light

Treatment with FLE demonstrated different benefits, such as influence in vitro the cell shape, cell proliferation, and production of major proteins involved in several skin healing processes.
Nikolis, A. et al. 2016 A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation

Evaluation of the efficacy and safety of the skin rejuvenation treatment with fluorescent light (FLE). Evaluation is done comparing skin biopsies and an increase of collagen from baseline.

Info

Articles scientifiques

Une collection de publications scientifiques sur Kleresca^®, qui démontrent ses avantages dans le traitement de différentes affections cutanées.

Trouvez ici la liste complète des articles

Gerber et al. (2019). Biophotonic pre-treatment enhances the targeting of senile lentigines with a 694nm QS-Ruby laser

Koceva, I. et al. Fluorescent light energy: A new therapeutic approach to effectively treating acne conglobata and hidradenitis suppurativa.

Edge, D. et al. Fluorescent light energy: the future for treating inflammatory skin conditions?

Liu, R. C. et al. 2019. Treatment of granulomatous rosacea with chromophore gel-assisted phototherapy

Mahendran, A. et al. 2018 Treatment of erlotinib-induced acneiform eruption with chromophore gel-assisted phototherapy

Carrasco & Jimenez, 2018. Biophotonic therapy in acne treatments (book chapter in ‘Acne: new therapies and cosmetic treatments’)

Sannino et al., 2018. Fluorescent Light Energy: Treating rosacea subtypes 1, 2 and 3

Jalili, A. 2018. Chromophore gel-assisted phototherapy - A novel and promising photobiomodulation therapy for facial inflammatory skin diseases and skin aging.

Antoniou, C. et al. 2016. A multicenter, randomized, split-face clinical trial evaluating the efficacy and safety of chromophore gel-assisted blue light phototherapy for the treatment of acne

Nikolis, A. 2018. An extension of a multicenter, randomized, split-face clinical trial evaluating the efficacy and safety of chromophore gel-assisted blue light phototherapy for the treatment of acne

Braun, S & Gerber, P. 2017. A photoconverter-gel assisted blue light therapy for the treatment of rosacea

Scarcella, G. et al. 2018. Treatment of solar lentigines using a combination of picosecond laser and biophotonic treatment

Nielsen, M. et al. 2017. Introducing: Photobiomodulation by low energy chromophore-induced fluorescent light

Nikolis, A. et al. 2016 A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation

Distribué par:

Marques de commerce © 2020 FB Dermatology

Contactez-nous

Info

Articles scientifiques

Une collection de publications scientifiques sur Kleresca®, qui démontrent ses avantages dans le traitement de différentes affections cutanées.

Trouvez ici la liste complète des articles

Vous voulez être contactés?

Distribué par:

Marques de commerce © 2020 FB Dermatology

Contactez-nous

Une collection de publications scientifiques sur Kleresca^®, qui démontrent ses avantages dans le traitement de différentes affections cutanées.